The story of Viagra, and its creator copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in income, its exclusivity period created a wave of knock-off medications, significantly eroding its market share . While specific pharmaceutical companies may try to capitalize on similar conditions , the p